Status:
COMPLETED
The Clinical Validation of a Dried Blood Spot Method for Vancomycin and Creatinine
Lead Sponsor:
Erasmus Medical Center
Conditions:
Vancomycin
Eligibility:
All Genders
18+ years
Brief Summary
A widely used antibiotic is vancomycin. To ensure adequate exposure to vancomycin, drug doses are adjusted based on whole-blood concentration measurements, a practice known as therapeutic drug monitor...
Eligibility Criteria
Inclusion
- Clinical patients
- Aged 18 and over
- Able to understand written information and able to give informed consent
- Treated with vancomycin
- Able and willing to undergo a finger prick for dried blood spot sampling
- Able and willing to fill in a questionnaire
Exclusion
- Unable to draw blood samples for study purposes
Key Trial Info
Start Date :
March 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05257070
Start Date
March 21 2022
End Date
March 1 2025
Last Update
March 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC
Rotterdam, Netherlands